USANA Health Sciences Inc. - Q1 2008 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 29, 2008. USANA Health Sciences, Inc. operates as a direct selling company developing and manufacturing nutritional and personal care products sold globally through a network of independent distributors ("Associates"). The company operates as a single reportable segment following the sale of its third-party contract manufacturing business in August 2007, which is now reported as discontinued operations.
Key Financial Metrics
| Metric (in thousands) | Q1 2008 | Q1 2007 |
|---|---|---|
| Net Sales | $101,570 | $100,678 |
| Gross Profit | $80,068 | $80,092 |
| Gross Margin | 78.8% | 79.6% |
| Operating Expenses | $68,111 | $61,980 |
| Net Earnings | $7,547 | $11,686 |
| Diluted EPS | $0.46 | $0.63 |
| Cash and Equivalents | $17,566 | $32,496 (End of Q1 2007) |
| Operating Cash Flow | $9,060 | $16,104 |
| Line of Credit Balance | $28,000 | $28,000 |
Material Changes vs. Prior Period
- Revenue Growth Stalled: Net sales increased only 0.9% year-over-year. This modest growth was driven by favorable foreign currency fluctuations, masking a decline in organic sales volume, particularly in North America.
- Profitability Decline: Income from continuing operations dropped 36.0% to $7.5 million. This was caused by minimal sales growth combined with a significant increase in operating expenses.
- Expense Increases: Selling, General, and Administrative (SG&A) expenses rose 19.9% to $25.8 million. Key drivers included increased associate support activities, wage-related expenses, facility expansion costs, and legal fees related to defending against false media allegations.
- Margin Compression: Gross margin decreased to 78.8% from 79.6% due to higher relative freight costs and period expenses.
- Customer Base Dynamics: Total active customers increased slightly by 0.4% to 241,000. However, North America saw a 3.0% decline in active customers, while Southeast Asia/Pacific and East Asia showed growth.
Outlook, Risks, and Management Commentary
Management Commentary: Management attributes the slowdown in sales growth to disappointing results from new promotional incentive activities, economic uncertainty in the U.S., and lingering effects of negative misinformation in the mass media during 2007. The company continues to invest in infrastructure and human capital to support long-term growth.
Liquidity and Capital Resources: The company maintains a $40 million line of credit with $28 million currently utilized for facility expansions in Salt Lake City, Utah, and Sydney, Australia. Management believes current cash balances and operating cash flows are sufficient for foreseeable needs, though additional financing may be required for future market expansion.
Risks and Contingencies:
- Legal: The company is a defendant in two class-action lawsuits; management believes an adverse outcome is remote.
- Operational: Risks include reliance on the network marketing system, ability to attract/retain associates, and regulatory scrutiny of network marketing practices.
- Market: Exposure to foreign currency fluctuations (58.2% of sales are international) and potential disruptions in shipping channels.
Investor Verification Checklist
- Verify the sustainability of sales growth in international markets (East Asia and Southeast Asia) versus the decline in North America.
- Monitor the effectiveness of new promotional incentive activities in reversing the trend of declining active associates in the U.S.
- Track the completion and cost overruns of the Salt Lake City and Sydney facility expansions funded by the line of credit.
- Assess the impact of ongoing legal defense costs on future SG&A expenses.
- Review foreign currency hedging strategies given that over 60% of sales are generated outside the U.S.